1-247758244-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012353.3(OR1C1):c.163C>T(p.Leu55Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000204 in 1,613,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012353.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR1C1 | NM_012353.3 | c.163C>T | p.Leu55Phe | missense_variant | 2/2 | ENST00000641256.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR1C1 | ENST00000641256.1 | c.163C>T | p.Leu55Phe | missense_variant | 2/2 | NM_012353.3 | P1 | ||
ENST00000662798.1 | n.1080+297G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000257 AC: 64AN: 249220Hom.: 0 AF XY: 0.000311 AC XY: 42AN XY: 135184
GnomAD4 exome AF: 0.000209 AC: 306AN: 1461796Hom.: 0 Cov.: 36 AF XY: 0.000228 AC XY: 166AN XY: 727186
GnomAD4 genome AF: 0.000151 AC: 23AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2024 | The c.163C>T (p.L55F) alteration is located in exon 1 (coding exon 1) of the OR1C1 gene. This alteration results from a C to T substitution at nucleotide position 163, causing the leucine (L) at amino acid position 55 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at